IOM: International Agreement Needed to Curb False, Unsafe Pharmaceuticals

The Institute of Medicine identified a need for an international agreement to reduce the amount of falsified, substandard and counterfeit pharmaceuticals in a new report.

Advertisement

At the request of the Food and Drug Administration, an IOM committee examined the global effects of falsified, substandard and counterfeit drugs in a report, “Countering the Problem of Falsified and Substandard Drugs.”

Click here to read the full report on IOM’s recommendations in Becker’s ASC Review.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.